WJET Erie on MSN4mon
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billion
As the FDA’s investigation continued, they ultimately decided to issue an involuntary recall, pulling all prescription and ...
GSK Class Action News: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Involving GSK PLC
SAN DIEGO, CA / ACCESS Newswire / February 10, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...
Hosted on MSN1mon
More Than 230,000 Bottles of a Popular Antidepressant Have Been Recalled Nationwide
Class II recalls represent the middle tier in a three ... duloxetine—including angiotensin II receptor blockers (ARBs), ranitidine, nizatidine, and metformin—have recently been recalled ...
WRAL2mon
Think all OTC medicine is safe? Think again, Zantac
While the FDA recall happened over a year ago, the statute of limitations for people who were diagnosed with cancer before the Zantac recall is in 2022. For those who believe they may have a case ...
Morningstar6d
Investor Alert: Robbins LLP Informs Stockholders of the GSK PLC Class Action
According to the complaint, in September and October 2019, GSK suspended its distribution of Zantac and initiated a voluntary recall. In April 2020, the FDA requested that manufacturers cease ...
TMCnet6d
Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between ...
Investor Alert: Robbins LLP Informs Stockholders Of The GSK PLC Class Action
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...